Article info
PDFHealth economics
Original research
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study
- Correspondence to Professor Giancarlo Pruneri; giancarlo.pruneri{at}istitutotumori.mi.it
Citation
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study
Publication history
- Received January 10, 2025
- Accepted April 23, 2025
- First published May 16, 2025.
Online issue publication
May 16, 2025
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.